Company Expects to Close Transactions in the First Quarter of 2025, Subject to Stockholder Approval and Other Closing Conditions The Company expects to close these transactions in the first quarter of ...

LOS ANGELES, Dec. 19, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (AADI) today announced it has entered into an exclusive license agreement for development and global commercialization of a three-asset ...